Skip to main content
. 2019 Apr 29;20(9):2123. doi: 10.3390/ijms20092123

Table 1.

Summary of the main findings, advantages, and disadvantages of the experimental models used for studying Brugada syndrome.

Model Major Findings Advantages Disadvantages
Murine SCN5A +/− mouse:
  • ~50% reduction in INa, slowed conduction, conduction block, re-entrant arrhythmias and ventricular tachycardia [22].

  • Age and sex-related factors in disease progression [24,25,26,27,28].

  • Reduced Nav1.5 protein expression [33,34].

  • Fibrosis-related to decreased Nav1.5 expression [34].

Scn5a 1798insD mouse:
  • Bradycardia, QT prolongation and right ventricular conduction slowing [39].

  • Strain dependence of conduction defect caused by the Scn5a1798insD/+ [41].

  • Allows integral studies from the whole animal, organ, tissue, and single cells.

  • Ion channels can be knock out or modified.

  • Size and electrophysiological differences with the human heart.

  • Profile of ion channel expression different to the human heart.

Canine
  • Correlation between epicardial notch AP amplitude and J wave amplitude [43].

  • Transmural dispersion of repolarization leading to ST-segment elevation [16,43].

  • Repolarization abnormalities associated with ST-segment elevation are located in the right ventricular outflow tract [49].

  • Male/female differences in susceptibility to Brugada syndrome are related to gender differences in Ito [53].

  • Focused application of RFA to the epicardium might be more efficient in eradicating ventricular tachycardia in Brugada syndrome patients [56].

  • Allows investigation of cells in epicardium and endocardium preserving their structural organization in the heart.

  • Electrophysiological similarities with the human heart.

  • Profile of ion channel expression similar to the human heart.

  • Brugada Syndrome phenotype has to be pharmacologically induced.

Porcine
  • Conduction slowing and increased susceptibility to ventricular arrhythmias [91]

  • Lack of a clear Brugada Syndrome [91].

  • Allows investigation of cells in epicardium and endocardium preserving their structural organization in the heart.

  • Electrophysiological similarities with the human heart.

  • Expensive.

  • Long reproductive cycles.

Heterologous expression See Supplementary Table
  • Relatively easy to perform.

  • Allows detailed studies of the intrinsic biophysical properties of ion channels affected by mutations.

  • Lack of many specific cardiac proteins.

  • Absence of patient-specific genetic background.

  • Results may vary according to the cell model (e.g.,: HEK cells vs. Xenopus oocytes).

iPS-CM
  • Reduced sodium current, increased triggered AP activity, and abnormal Ca2+ transients. Genome editing reversed the effects of the mutation, indicating causality [78].

  • Patients with no mutation identified do not present current abnormalities [79,80].

  • Decrease in current correlated with a reduction of the maximum upstroke velocity and AP amplitude [82].

  • Mutation-induced changes, other than current density may appear in patient-specific iPS-CM, but not in heterologous expression recordings [83].

  • No changes in sodium current were observed in iPS-CM from patients without SCN5A mutation [79].

  • Patient-specific iPS-CM carry the patient’s exact genetic background.

  • iPS-CM expression profile closely resembles that of cardiomyocytes.

  • iPS cells are suitable for genome editing.

  • Immature phenotype.

  • Depolarized membrane potential compared with adult cardiomyocytes.

  • Negligible levels of IK1.

  • Poor ultrastructural organization regarding sarcomere and t-tubule development.